Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Covid-19 Pandemic and Current Medical Interventions

(2020) Sweeta Manhas et al.   ARCHIVES OF MEDICAL RESEARCH

Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study

(2020) Corrado Campochiaro et al.   European Journal of Internal Medicine

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

COVID-19: consider cytokine storm syndromes and immunosuppression

(2020) Puja Mehta et al.   LANCET

Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients

(2020) T. Klopfenstein et al.   MEDECINE ET MALADIES INFECTIEUSES

Remdesivir for the Treatment of Covid-19 — Preliminary Report

(2020) John H. Beigel et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19

(2020) Bin Cao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE)

(2020) Marta Colaneri et al.   Microorganisms

The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review

(2020) William Gustavo Lima et al.   ARCHIVES OF VIROLOGY

May IL-17 have a role in COVID-19 infection?

(2020) Matteo Megna et al.   MEDICAL HYPOTHESES

Clinical characteristics of 82 cases of death from COVID-19

(2020) Bicheng Zhang et al.   PLoS One

Inflammasome formation in the lungs of patients with fatal COVID-19

(2020) Stefano Toldo et al.   INFLAMMATION RESEARCH

Development and Evaluation of a Multiplexed Immunoassay for Simultaneous Detection of Serum IgG Antibodies to Six Human Coronaviruses

(2019) Suvang U. Trivedi et al.   Scientific Reports

A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy

(2014) Angeline XH Goh et al.   mAbs